COL1A1 and metabolic dysfunction-associated steatohepatitis: NASH patients show significantly higher fibrogenesis (Figure 1B), as demonstrated by collagen 1 (gene COL1A1), and inflammation (Figure 1C) than control patients, as demonstrated by macrophage and Kupffer cell marker EMR1 (gene ADGRE1).